Results 131 to 140 of about 6,607,101 (361)

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Geometry of static w = - 1 / 5 perfect fluid spheres in general relativity. [PDF]

open access: yesEur Phys J C Part Fields, 2022
Fazlpour B, Banijamali A, Faraoni V.
europepmc   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Nonlocal teleparallel cosmology

open access: yesEuropean Physical Journal C: Particles and Fields, 2017
Even though it is not possible to differentiate general relativity from teleparallel gravity using classical experiments, it could be possible to discriminate between them by quantum gravitational effects. These effects have motivated the introduction of
Sebastian Bahamonde   +3 more
doaj   +1 more source

Black hole binary OJ287 as a testing platform for general relativity [PDF]

open access: diamond, 2014
M. J. Valtonen   +4 more
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy